CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-21 | Lin Celia Chief Medical Officer | Sale 10b5-1 | −1,490 | $16.65 | $25K | 11,010 |
| 2023-02-15 | Lin Celia Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-08-19 | Lin Celia Chief Medical Officer | Grant or award | +12,500 | 12,500 | ||
| 2022-02-16 | Lin Celia Chief Medical Officer | Grant or award · Stock Option (right to buy) | +52,412 | 52,412 | ||
| 2021-05-13 | Lin Celia Chief Medical Officer | Grant or award · Stock Option (right to buy) | +16,916 | 16,916 |
Page 1 of 1 · 5 trades